6-Amino-2-bromonicotinic acid is primarily used as a key intermediate in the synthesis of various pharmaceutical compounds. It plays a significant role in the development of active pharmaceutical ingredients (APIs), particularly in the production of drugs targeting neurological and cardiovascular diseases. Its structure allows for further functionalization, making it valuable in creating complex molecules with therapeutic potential. Additionally, it is utilized in organic synthesis for constructing heterocyclic compounds, which are essential in medicinal chemistry for designing new drugs with specific biological activities. Its application extends to research laboratories, where it is employed in the study of chemical reactions and the development of novel synthetic pathways.